Thermo Fisher Scientific MagMax DNA Multi-Sample Ultra 2.0
Thermo Fisher Scientific has released MagMax DNA Multi-Sample Ultra 2.0 reagents for DNA extraction from blood, saliva, buffy coat, and buccal swabs. With Thermo Scientific KingFisher instruments, customers can use the reagents to purify DNA from 96 samples in 45 minutes, with five minutes of hands-on time, using a protocol for either small-volume or large-volume samples.
Admera Health PGxOnco and LiquidGx Tests
Admera Health has launched two new tests: PGxOnco for cancer supportive care, and LiquidGx, a suite of liquid biopsy-based tests for tumor profiling and drug resistance monitoring. The PGxOnco test includes 50 genes and about 200 variants, and provides recommendations for over 300 drugs via next-generation sequencing. LiquidGx represents a menu of both qPCR and a NGS tests that analyze tumor DNA in blood samples. PCR assays allows for the genotyping of ALK, BRAF, EGFR, and KRAS either individually or together. The NGS panel, aimed specifically at lung cancer, includes AKT1, BRAF, ERBB2, MET, RET, ALK, EGFR, KRAS, PIK3CA,and ROS1.
Cancer Genetics AntigenID
Cancer Genetics has launched a neoantigen discovery service it calls AntigenID designed to identify neoantigens and neoantigen signatures that can accelerate immuno-oncology drug discovery, predict patient-specific immune therapy response, and help create personalized immuno-vaccines. AntigenID incorporates genomic and transcriptomic profiles, HLA typing, and bioinformatic strategies, the company said.
For more new products and services, please visit the New Products page on our website.